MapLight Therapeutics Inc. (MPLT)
MPLT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.88
-8.43% on the day
Market cap
$510.1M
Small cap
Revenue
Recent IPO: no annual report filed yet
Net income
Recent IPO: no annual report filed yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | MPLT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2025 |
| SEC CIK | 0001770069 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Recent IPO: no annual report filed yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-09-23 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-08-13 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 196 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -17.4% |
| 1 month | -36.0% |
| 3 months | -79.2% |
| Year to date | -56.0% |
| 1 year | Not enough price history |
| From 52-week high | -80.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc. | $3.47 | -3.61% | $510.8M |
| CTMX | CytomX Therapeutics Inc. | $2.33 | -3.93% | $506.6M |
| DRUG | Bright Minds Biosciences Inc. | $51.36 | -4.91% | $504.3M |
| PBYI | Puma Biotechnology Inc | $10.12 | -1.65% | $522.4M |
| EOLS | Evolus Inc. | $7.51 | -3.10% | $496.0M |
| BLSM | BlossomHill Therapeutics Inc. | $15.48 | -10.37% | $492.0M |
| MNPR | Monopar Therapeutics Inc. | $72.08 | -6.45% | $483.8M |
| CBIO | Crescent Biopharma Inc. | $12.91 | -10.72% | $479.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier